New York—November 18, 2011
Judge Maryanne Trump Barry, Donald Trump, Robert Trump, and Elizabeth Trump Grau have provided Hospital for Special Surgery with a $1 million gift in support of and to name the Institute for Implant Analysis in honor of their parents, the late Mary and Fred Trump.
Mr. and Mrs. Fred Trump were grateful patients of Philip Wilson, Jr., M.D., an orthopedic surgeon at Hospital for Special Surgery and surgeon-in-chief from 1972 to 1989. The Trumps made a commitment of $1 million to the Hospital in honor of their parents and in recognition of Dr. Wilson’s 91st birthday.
“Receiving this donation on behalf of the Hospital is the most important and meaningful birthday gift I could have ever hoped for,” said Dr. Wilson, who has been an orthopedic surgeon at Hospital for Special Surgery for 60 years. “It means that countless people suffering from painful and disabling joint disorders, and who are in need of new medical treatments, will be the ultimate benefactors of the Trump family’s generosity.”
Translating discoveries in the laboratory to improve patient care has been a hallmark of Hospital for Special Surgery’s Department of Biomechanics for decades, starting with the design and fabrication of the first practical knee implant in the early 1970s. The Hospital’s Institute for Implant Analysis, under the direction of Timothy Wright, Ph.D., F.M. Kirby Chair in Orthopaedic Biomechanics, and Douglas Padgett, M.D., chief of Adult Reconstruction and Joint Replacement, has been at the forefront of implant research and design, helping to better treat the pain and disabilities associated with aging and worn joints.
“Our surgeons perform an exceptionally large volume of joint replacement surgeries, nearly 8,400 each year,” said Thomas Sculco, M.D., surgeon-in-chief. “The new Mary and Fred Trump Institute for Implant Analysis will allow us to accelerate patient-oriented research to enhance the mobility and quality of life for countless current and future joint replacement patients.”
The Institute has the largest collection of retrieved joint replacements in the world, and has maintained a registry for nearly 34 years. The analysis of these retrieved implants has allowed Hospital for Special Surgery surgeons and engineers to establish the mechanical performance of new implant designs and to determine the influence of patient characteristics and surgical variations. As a result, the role that design played in establishing how well the joint replacement components performed and endured is helping in the development of the next generation of advances in implant design.
“Thanks to the generous support of donors like the Trump family, Hospital for Special Surgery is able to offer patients the highest level of orthopedic care and to continue as leaders in translating research into cutting edge treatments,” said Louis A. Shapiro, president and CEO of Hospital for Special Surgery.
About HSS | Hospital for Special Surgery
HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the ninth consecutive year) and No. 3 in rheumatology by U.S.News & World Report (2018-2019). Founded in 1863, the Hospital has one of the lowest infection rates in the country and was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center four consecutive times. The global standard total knee replacement was developed at HSS in 1969. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State. In 2017 HSS provided care to 135,000 patients and performed more than 32,000 surgical procedures. People from all 50 U.S. states and 80 countries travelled to receive care at HSS. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 laboratories and 300 staff members focused on leading the advancement of musculoskeletal health through prevention of degeneration, tissue repair and tissue regeneration. The HSS Global Innovation Institute was formed in 2016 to realize the potential of new drugs, therapeutics and devices. The culture of innovation is accelerating at HSS as 130 new idea submissions were made to the Global Innovation Institute in 2017 (almost 3x the submissions in 2015). The HSS Education Institute is the world’s leading provider of education on the topic on musculoskeletal health, with its online learning platform offering more than 600 courses to more than 21,000 medical professional members worldwide. Through HSS Global Ventures, the institution is collaborating with medical centers and other organizations to advance the quality and value of musculoskeletal care and to make world-class HSS care more widely accessible nationally and internationally.